Vertex Pharmaceuticals Incorporated: Analyst Cory Kasimov Provides Update From ...
Smarter Analyst
J.P. Morgan analyst Cory Kasimov is out today with an update on Vertex Pharmaceuticals Incorporated (NYSE:VRTX), straight from the 2016 J.P. Morgan Healthcare Conference. The analyst rates the stock an Overweight with a price target of $153, which ...and more »